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Background:Malaria parasites possess two unusual class XIVmyosins, myosin A that drives gliding motility and myosin B
that is uncharacterized.
Results: Myosin B is located at the extreme apical end of motile and invasive parasites, binding a very large and unusual light
chain.
Conclusion:Myosin B differs substantially from myosin A in location and function.
Significance: An unusual myosin and its light chain extend the known diversity of these families.
Myosin B (MyoB) is one of the two short class XIV myosins
encoded in the Plasmodium genome. Class XIV myosins are
characterized by a catalytic “head,” a modified “neck,” and the
absence of a “tail” region.Myosin A (MyoA), the other class XIV
myosin in Plasmodium, has been established as a component of
the glideosome complex important inmotility and cell invasion,
but MyoB is not well characterized.We analyzed the properties
of MyoB using three parasite species as follows: Plasmodium
falciparum, Plasmodium berghei, and Plasmodium knowlesi.
MyoB is expressed in all invasive stages (merozoites, ookinetes,
and sporozoites) of the life cycle, and the protein is found in a
discrete apical location in these polarized cells. InP. falciparum,
MyoB is synthesized very late in schizogony/merogony, and its
location in merozoites is distinct from, and anterior to, that of a
range of known proteins present in the rhoptries, rhoptry neck
or micronemes. Unlike MyoA, MyoB is not associated with
glideosome complex proteins, including the MyoA light chain,
myosin A tail domain-interacting protein (MTIP). A unique
MyoB light chain (MLC-B) was identified that contains a cal-
modulin-like domain at the C terminus and an extended N-ter-
minal region. MLC-B localizes to the same extreme apical pole
in the cell as MyoB, and the two proteins form a complex. We
propose that MLC-B is a MyoB-specific light chain, and for the
short class XIVmyosins that lack a tail region, the atypical myo-
sin light chains may fulfill that role.
The malaria parasite genome contains six genes that encode
myosins (1, 2). Two of these genes code for short class XIV
myosins, which are restricted to Apicomplexan parasites and
other members of the Alveolata. These myosins differ from
most others in that, although they have the highly conserved
“head” region that binds actin and hydrolyzes ATP, and the
“neck” region that acts as the lever arm and contains IQ motifs
to which myosin light chains bind, they have no “tail” region.
The tail normally allows oligomerization, cargo binding, and
determines the subcellular location of the myosin (3). Of the
two short class XIV myosins encoded by Plasmodium falcipa-
rum, myosin (Myo)5A is the most studied and has been impli-
cated as providing the power for gliding motility and cell inva-
sion as part of the glideosome complex (4, 5). The glideosome
complex is found between the parasite plasma membrane and
the underlying innermembrane complex. It also containsmyo-
sinA tail domain-interacting protein (MTIP), which is amyosin
light chain, together with glideosome-associated proteins
(GAP) 45, GAP50, and GAP40 (5). Despite its name, MTIP
binds to the C-terminal part of MyoA, which should strictly be
called a neck rather than tail domain (6–10). It is themembrane
association of MTIP and the GAPs that confers inner mem-
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brane complex localization upon MyoA (11–14). In contrast,
the second short class XIVmyosin,MyoB, has not been studied
in detail, and its properties are largely unknown.There has been
one report of the location of P. falciparum MyoB, which
described it as localized within merozoites (15).
In this study, we have tagged MyoB with GFP and HA and
examined its expression and cellular localization both within
the asexual blood stage development of P. falciparum and Plas-
modium knowlesi and throughout the life cycle of Plasmodium
berghei. We identify a new and unusual myosin light chain that
binds to a region at the C terminus of MyoB through a
calmodulin-like domain. The myosin light chain contains an
extended N terminus when compared with other more typical
light chains, and we propose this may be acting as a tail domain
for MyoB. We also identify a unique apical localization for this
complex in invasive stages of the parasite.
EXPERIMENTAL PROCEDURES
Ethics Statement for AnimalWork
All animal work passed an ethical review process and was
approved by the United KingdomHomeOffice. Work was car-
ried out in accordance with the United Kingdom Animals (Sci-
entific Procedures) Act of 1986 and in compliance with Euro-
pean Directive 86/609/EEC for the protection of animals used
for experimental purposes. The project license number is
40/3344. Six- to 8-week-old female Tuck-Ordinary (TO) out-
bred mice (Harlan) were used for all experiments.
Parasite Genetic Modification
GFP Tagging of P. falciparum MyoB and MyoA—A 1069-bp
sequence from the 3 end of the P. falciparum 3D7myoB ORF
without the stop codon was amplified from genomic DNA by
PCR using primer pairs 1 and 2 (all primers used are listed in
Table 1) and cloned between theXmaI/AvrII sites of the pHH4-
GFP plasmid6 generating the construct pHH4-PfMyoB-GFP in
which the targeting fragment was placed upstream of the GFP
ORF followed by the P. berghei dhfr 3UTR. The correct
sequence of the plasmid was confirmed by Sanger sequencing
(Beckman Genomics). After transfection of ring stage parasites
with 100 g of plasmid DNA, 2.5 nMWR99210 was added, and
the parasites were cultured continuously under drug selection
for 3 weeks (designated cycle 0). The transfected parasites
were then grown for 3 weeks without drug selection, to allow
loss of episomal DNA followed by a further week of growth
under WR99210 selection (cycle 1). The cycling was repeated
onemore time. Cultures were checked after each cycle for inte-
gration of the construct into the genome by diagnostic PCR
using primer pairs 3 and 4 to detect integration and primer
pairs 3 and 5 to detect the unmodified locus and for GFP
expression by fluorescence microscopy. After confirmation of
correct integration, parasite lines were cloned by limiting dilu-
tion. A scheme for parasite integration, diagnostic PCR, and
Southern blot is shown in Fig. 1.
6 E. Knuepfer and A. A. Holder, unpublished data.
TABLE 1
Oligonucleotide primers used in this study
Primers used in this study are listed with nonhomologous sequences in lowercase, restriction enzyme sites in lowercase italic, and nonhomologous sequences introduced
to generate a unique restriction site in bold, lowercase font.
ID Oligonucleotide sequence Description
1 cccgggGGACATCCTTTCGCCTAACATTTTGAAA PfMyoB-F
2 cctaggTTCGTGTTCCTTAATATATTTATATTTCCTAAAATATGC PfMyoB-R
3 CATAACGGAAAGTTTTGTAATTAAGCATACTGTAAGTGATG diagPfMyoB-F
4 GGATGACCAGAAAGTTGTAACTTTGGCAAATTTATTC diagPfMyoB-R
5 CTCCAGTGAAAAGTTCTTCTCC GFP-R
6 ttttaacccgggGCGTGATATCCATTTTGGAGG PkMyoB-F
7 cccattcctaggCTTCAGCTGTGCAATGTACTTATG PkMyoB-R
8 GATCATCGCTGAGTCTGTGAAG diagPkMyoB-F
9 GTGTGTAGTGAACGAGTACAACG diagPkMyoB-R
10 CCTTTACCGCGGTCAAGCGTAATCTGGAACGTCGTAAGGGTAGCCCATGG HA-R
11 ccccggtaccATACCGTAAGTGATGTAACATATACTATTAC PbMyoB-F
12 ccccgggcccTTCGAGCTCTTTCATATGCTTATATTTTCG PbMyoB-R
13 CGAAGCATGCAAAATATGCTTCTACAAAG diagPbMyoB-F
14 ACGCTGAACTTGTGGCCG diagPbMyoB-R
15 cccgggCAAGAATTGAACCAGAAGGAGGATTTAAAAC PfMyoA-F
16 cctaggTTGAGCTACCATTTTTTTTCTTATATGAGCTTGTA PfMyoA-R
17 GGGAAATATTAATTAAGGTAACTGTTGCTGGAGGAAC diagPfMyoA-F
18 CACTCATAGATGCAACATGTAAGTATACAAATAAATATGGTATGTAG diagPfMyoA-R
19 cccgggAGGAGACGTTAAGTTTGGAGAA PfMLC-B-F
20 cctaggTTCTTCGGTTCCATAAATCCA PfMLC-B-R
21 ATATGTATGTATGCTATAATGGGTTAT diagPfMLC-B-F
22 GGACAAAATGGAAAAGTTTTTTTTTAGACAATGTAGAG diagPfMLC-B-R
23 cccgggTGTGAATCATCTGCAATACGGCAGGAA PkMLC-B-F1
24 cctagggtgtgtggtaccGACACGTCGAAGATACTCTCCCCGTTT PkMLC-B-R1
25 ggtACCCAGCTATACCATTCTCCCACAT PkMLC-B-F2
26 cctaggCTCCCCTGTTCCTTGGATCCA PkMLC-B-R2
27 gtcaggatccGAAGAACAAGAATTATTAGAAGAA PfMLC-B-CTDexpF
28 gtcactcgagTTATTCTTCGGTTCCATAAATCCA PfMLC-B-CTDexpR
29 GAAAATATAAGAGTAGTATCACAGGAAG PbMyoB-RT-FW
30 CTATCATCAATTTCTGGTATAACCAC PbMyoB-RT-RV
31 GTATTATTAATGAACCCACCGCT Pbhsp70FW
32 GAAACATCAAATGTACCACCTCC Pbhsp70RV
33 TTGATTCATGTTGGATTTGGCT PbarginylFW
34 ATCCTTCTTTGCCCTTTCAG PbarginylRV
35 gatcggatccAAAATTGAGGAATTGGAAATGAACATTAGTTATTGTG PfMLC-B-CCexpF
36 gatcctcgagTTACTCCTTATTTTTCTCGGATATCTTCTTGGT PfMLC-B-CCexpR
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Aparasite line expressingMyoA-GFPwas prepared in a sim-
ilar fashion. A region of homology corresponding to the final
1057 bp of the P. falciparum myoA gene was amplified from
genomic DNA using primers 15 and 16 and cloned into the
pHH4-GFP plasmid exactly as described for Pfmyob. A scheme
for integration and its analysis by Southern blot and diagnostic
PCR using primer pairs 17 and 5 to detect integration and 17
and 18 to detect the unmodified locus is shown in Fig. 1,
together with the pattern of GFP fluorescence in the parasite.
HA Tagging of P. knowlesi MyoB—A 1316-bp DNA fragment
corresponding to the 3 end of the PkmyoB gene was amplified
using primers 6 and 7 and cloned via XmaI/AvrII sites into the
pHH4PK vector by having replaced the sequence coding for
GFP with a sequence coding for a triple HA epitope tag. The
vector was linearized using SwaI, and 10 g of DNA was trans-
fected as described previously (16). A scheme for construct
integration and diagnostic PCR screening with primer pairs 8
and 10 to detect integration and 8 and 9 to detect the unmodi-
fied locus are shown in Fig. 2.
GFP Tagging of P. berghei MyoB—P. berghei myoB was mod-
ified by single homologous recombination to insert a sequence
coding for a C-terminal GFP tag, using the p277 vector that
contains a human dhfr selection cassette (Fig. 2E) (17). A
978-bp sequence of myoB starting 2.4 kb downstream of the
ATG initiator codon andomitting the stop codonwas amplified
using primers 11 and 12 and inserted into the vector using KpnI
and ApaI restriction sites. The construct was linearized using
HincII and then used to transfect the P. bergheiANKA 2.34 line
by electroporation (18). The electroporated parasites were
mixed immediatelywith 150l of reticulocyte-rich blood, incu-
bated at 37 °C for 30 min, and then injected intraperitoneally
into naivemice. Pyrimethamine (Sigma) at 7mg/mlwas admin-
istered to the drinking water for 4 days to select resistant para-
sites. Mice were monitored for 10 days to detect parasites, and
the drug selection was repeated after parasite passage to a sec-
ond mouse. Pyrimethamine-resistant parasites were then ana-
lyzed with a diagnostic PCR using primers 13 and 14 to deter-
mine correct integration of the gfp sequence at the targeted
locus (Fig. 2F), and a Western blot was performed to confirm
the size of the GFP-tagged protein (Fig. 2G).
GFP Tagging of P. falciparum MLC-B—A 1034-bp fragment
of homology targeting the mlc-b locus (PF3D7_1118700) was
amplified from3D7 genomicDNAusing the primer pair 19 and
20. The PCR fragment was inserted into pHH4-GFP between
the XmaI and AvrII sites, verified by sequencing, and trans-
fected into 3D7 parasites as above. WR99210-resistant para-
sites were cloned by limiting dilution. Parasites were screened
for integration into the mlc-b locus by diagnostic PCR using
primer pairs 21 and 5 to detect integration and 21 and 22 to
detect the unmodified locus, as shown in Fig. 3A.
HA Tagging of P. knowlesi MLC-B—A 1198-bp region of ho-
mology representing 3739–4933 bp from pkmlc-b was cloned
into the XmaI/AvrII sites of pHH4PK-HA vector using a two-
step approach. A region of pkmlc-b from 3739 to 4308 bp was
amplified from genomic DNA using the primer pair 23 and 24,
where underlining denotes the introduced unique KpnI site.
After cloning into pGEM-TEasy and sequence verification, this
region was excised and cloned into the XmaI/AvrII sites of the
pHH4PK-HA vector. A second region of pkmlc-b from 4309 to
4933 bp was amplified using the primer pair 25 and 26, where
nonhomologous sequences were introduced to generate the
KpnI site. After cloning into pGEM-T Easy and sequence veri-
fication, this regionwas excised and cloned into the KpnI/AvrII
sites of the pHH4PK-mlc-b-HA vector generated in the previ-
ous step. This plasmid was linearized with AleI prior to trans-
fection into P. knowlesi (Fig. 3B) (16).
Analysis of PbMyoB Gene Expression by Quantitative
RT-PCR—Blood stage P. berghei parasites from infected mice
(day 4 post-infection) were cultured in vitro (40 ml of RPMI
1640 medium, 8 ml of fetal bovine serum, 0.5 ml of penicillin
and streptomycin per 0.5 ml of blood) for 24 h at 37 °C (with
rotation at 100 rpm). The following day, schizont-infected cells
were purified on a 60% v/vNycoDenz/PBS gradient (NycoDenz
stock solution: 27.6% w/v NycoDenz in 5 mM Tris-HCl, 3 mM
KCl, 0.3 mM EDTA, pH 7.2). The purification of gametocytes
was based on a modified protocol described in Beetsma et al.
(19). On day 4 post-infection, parasites were harvested, kept on
ice to avoid premature activation, and separated from unin-
fected erythrocytes on a 48% (v/v) NycoDenz in coelenterazine
loading buffer (CLB) gradient (CLB: PBS containing 20 mM
HEPES, 20mMglucose, 4mM sodiumbicarbonate, 1mMEGTA,
0.1% w/v bovine serum albumin, pH 7.25). Gametocytes were
harvested from the interface and washed twice in RPMI 1640
medium before activation of gamete formation in ookinete
medium (20) for 30 min at 20 °C. For ookinete preparation,
parasites fromday 5 post-infectedmicewere placed in ookinete
medium for 24 h at 20 °C; the parasites were then lysed in red
blood cell lysis buffer for 30 min and purified on a 63% Nyco-
Denz gradient (v/v in PBS). On day 14 post-feeding, guts were
dissected and crushed in a loosely fitting homogenizer to
release sporozoites, which were then quantified using a hemo-
cytometer (20).
Total RNA was isolated from purified parasites using an
RNeasy purification kit (Qiagen). cDNA was synthesized using
an RNA-to-cDNA kit (Applied Biosystems) allowing quantifi-
cation from 250 ng of total RNA. Each quantitative PCR con-
sisted of 2 l of cDNA, 5 l of SYBR Green fast master mix
(Applied Biosystems), 0.5 l (500 nM) each of the forward and
reverse primers, and 2 l of diethyl pyrocarbonate-treated
water. Where possible, one of the primer pairs was placed over
an intron and together they amplified a region 70–200 bp long.
Analysis was conducted using an Applied Biosystems 7500 fast
machine with the following cycling conditions: 95 °C for 20 s
followed by 40 cycles of 95 °C for 3 s; 60 °C for 30 s. Wild-type
expression was determined using the Pfaffl method (21). The
method used hsp70 (PBANKA_081890) and arginyl-tRNA syn-
thetase (PBANKA_143420) as reference genes. All primers
used are listed in Table 1 (primers 29–34).
Antibodies
Polyclonal rat anti-PfMyosin B antibodies were raised to a
peptide of the sequence MVNKINELNNYFRINSTFINKSENE
by Pepceuticals Ltd. according to their standard protocol. Rab-
bit anti-EBA175 andmouse anti-RAP1 (7H8/54) were obtained
from the Malaria Research and Reference Reagent Resource
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FIGURE 1. Generation of PfMyoB-GFP and PfMyoA-GFP parasites. A, schematic representation of the GFP-tagging of PfMyoB by single crossover homol-
ogous recombination into themyoB locus. Theprimers for PCR (arrows 1 and 2) and the Southernblot probe togetherwith restriction sites are labeled.XXbaI
andHHpaI. B,diagnostic PCR on genomicDNA showing integration of PfMyoB-GFP (primers 35) andwild type (primers 34). Two PfMyoBGFP cloneswere
examined. C, Southern blot analysis of cloned PfMyoB-GFP parasites. GenomicDNAwas digestedwith XbaI andHpaI restriction enzymes. A probe to themyob
region of homology showed the following: PfMyoB-GFP cycle 0 (c0) shows the presence of wild-type (8.4 kb) and episome (4.3 kb) bands; 3D7 parasites only
show the wild-type band. Clone 1 shows the expected bands for integration (7.9 and 4.8 kb), but also for episome, suggesting concatamer insertion. Clone 2
shows only bands for integration and was therefore used in all subsequent experiments. D, Western blot. Extracts of late stage schizonts from 3D7 and
PfMyoB-GFP clone 2 parasites were immunoblotted wth an anti-GFP antibody. MyoB-GFP protein of120 kDa was detected in clone 2. E, schematic repre-
sentationof theGFP taggingofMyoAby single crossover homologous recombination into themyoA locus,withprimers for PCR (arrowswithprimerpair 15 and
16) and Southern blot probe and restriction sites labeled. C  ClaI and B  BsrFI. F, diagnostic PCR on genomic DNA showing integration of PfMyoA-GFP
(primers 175) and wild type (primers 1718). Four PfMyoA-GFP-expressing clones were examined. G, PfMyoA-GFP-expressing merozoites as viewed by live
fluorescencemicroscopy. GFPwas detected by green fluorescence, and the nuclei (blue) were labeledwith Hoechst dye prior tomicroscopic analysis; the GFP
signal is distributed to the parasite periphery. Scale bar, 2 m. H, Southern blot analysis of cloned PfMyoA-GFP-expressing parasites. Genomic DNA was
digested with ClaI and BsrFI. When probed with themyoa region of homology, all clones showed the expected two integration bands at 11.1 and 2.5 kb. 3D7
is the wild-type control and shows a band of the expected size (7.3 kb).
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Centre. Mouse anti-RON4 was a gift from Dr. J-F Dubremetz
(University of Montpellier). Anti--tubulin mAb clone DM 1A
(T9026, Sigma) was used to detect P. falciparum -tubulin.
Rabbit anti-GFP6 and rat anti-HA (monoclonal 3F10, Roche
Applied Science) antibodies were used to detect tagged pro-
teins. Species-specific AlexaFluor 488- and 594-conjugated
secondary antibodies were obtained from Molecular Probes
(Life Technologies, Inc.).
Microscopy
Live Imaging of GFP-tagged Parasite Lines—P. falciparum
and P. knowlesi parasite-infected red blood cells were prepared
for live imaging as described in Ridzuan et al. (22) and viewed
using anAxio ImagerM1microscope (Zeiss). P. berghei asexual
blood stage infections in mice were initiated by intraperitoneal
injection of parasite-infected blood. The asexual, gametocyte,
FIGURE 2. Generation of PkMyoB-HA and PbMyoB-GFP and detection of myob throughout the P. berghei life cycle. A, diagram representing
C-terminal tagging of Pkmyob with a triple HA tag. Primers shown (arrows) were used to amplify the region of homology (6 and 7) for diagnostic PCR of
WT parasite sequences (8 and 9) or parasites where integration had taken place (8 and 10). B, diagnostic PCR on genomic DNA showing integration of
PkMyoB-HA into the myob locus in clone c1 with parental H.1 DNA as a control. C, Western blot with an anti-HA antibody on parental PkH.1 and
PkMyoB-HA parasite lysates. In PkMyoB-HA parasites, a protein of 90 kDa is detected. The same blot was probed with an antibody against BiP to
demonstrate equivalent sample loading. D, quantitative RT-PCR to show mRNA expression of Pbmyob during the parasite life cycle. Arginyl-tRNA
synthetase and hsp70were used as endogenous controls for normalization. Bars, three biological replicates, each S.E. AS, all asexual blood stages; Sch,
schizonts; NG, nonactivated gametocytes; AG, activated gametocytes; Ook, ookinetes; Spz, sporozoites. E, diagram representing C-terminal tagging of
PbMyoB with GFP by single homologous recombination into endogenous myob gene, showing primers 11 and 12 to amplify the region of homology,
and primers 13 and 14 to detect integration. F, confirmation of integration by PCR of Pbmyob-gfp using primer pair 13 and 14. G,Western blot of extracts
of parasites expressing PbMyoB-GFP or GFP.
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and ookinete stages were observed using Hoechst 33342 dye in
ookinete medium. To examine mosquito mid-gut infection,
guts were dissected 14 days after feeding on infected blood and
mounted under Vaseline-rimmed coverslips after staining with
Hoechst dye for 10–15 min. On day 21 post-feeding, guts and
salivary glands were dissected and crushed separately in a
loosely fitted homogenizer to release sporozoites, which were
then quantified using a hemocytometer and used for imaging
(20). Microscopy analysis was performed using a Zeiss Axio-
ImagerM2microscope (Carl Zeiss, Inc) fittedwith anAxioCam
ICc1 digital camera.
For P. berghei liver stage parasites, 60,000 HepG2 cells were
seeded in glass-bottomed imaging dishes. Salivary glands of
femaleAnopheles stephensimosquitoes infected with PbMyoB-
GFPparasiteswere isolated anddisrupted using a pestle. Sporo-
zoites were pipetted gently onto seeded HepG2 cells and incu-
bated at 37 °C in 5% CO2 in complete minimum Eagle’s
medium containing 2.5g/ml amphotericin B (PAA). Medium
was changed 3 h after initial infection and once a day thereafter.
For live cell imaging, Hoechst 33342 (Molecular Probes) was
added to a final concentration of 1 g/ml, and parasites were
imaged 24, 48, and 55 h post-infection using an epi-fluores-
cence microscope (DMI600B from Leica).
Indirect Immunofluorescence Assay—Thin smears of para-
sites were fixed with 4% paraformaldehyde for 30 min at room
temperature. The fixed cells were permeabilized with PBS con-
taining 0.1% Triton X-100 for 5 min followed by blocking in 3%
BSA (w/v) in PBS at 4 °C overnight. Primary antibodies were
diluted as required; species-specific Alexa Fluor 488- and 594-
conjugated secondary antibodies (Life Technologies, Inc.) were
used to visualize primary antibody binding. All antibody dilu-
tions were carried out with 3% BSA (w/v) in PBS. Slides were
mounted for microscopic examination using Prolong Gold
antifade reagent with DAPI (Life Technologies, Inc.). Slides
were viewed using a Zeiss Axioplan 2 microscope, and images
were captured using a Zeiss Axiocam MRc digital camera and
AxioVision 4.8.2 software and prepared for publication using
Adobe Photoshop.
To image stages of invasion of erythrocytes, tightly synchro-
nized PfMyoB-GFP-expressing late stage schizonts weremixed
with erythrocytes, and samples were taken after 2, 5, 8, 10, and
30 min and fixed in solution with 4% paraformaldehyde, 0.01%
glutaraldehyde for 60 min at room temperature. Further pro-
cessing was carried out as described previously (23).
Preparation of Parasite Lysates, Immunoprecipitation of GFP
Fusion Proteins, and Analysis of the Precipitates byWestern
Blotting and LC-MS/MS
Parasite Lysates—Schizonts from the MyoB-GFP, MyoA-
GFP, MLC-B-GFP, and 3D7 parasite lines were first lysed in
0.15% (w/v) saponin in PBS and harvested by centrifugation,
and the proteins were extracted using 10 cell pellet volumes of
ice-cold lysis buffer (0.5% Nonidet P-40, 150 mM NaCl, 10 mM
Tris-HCl, pH 7.5, 1 Complete protease inhibitors (Roche
Applied Science)). Samples were cleared by centrifugation at
100,000  g for 10 min. The detergent concentration in the
samples was reduced to 0.2% by dilution with 150 mM NaCl,
10 mM Tris, pH 7.5, 1 Complete protease inhibitors.
Immunoprecipitation—Parasite lysates were pre-cleared by
incubation with blocked agarose beads (Chromotek) for 1 h,
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FIGURE 3. Generation of PfMLC-B-GFP and PkMLC-B-HA parasites. A, panel i, schematic representation of the GFP tagging of PfMLC-B by single crossover
homologous recombination into the pfmlc-b locus. Primer pair 19 and 20were used to amplify the region of homology. Primer pair 21 and 22 amplify from the
wild-type locus, and pair 21 and 5were used to detect integration of the plasmid into the target locus. Panel ii, diagnostic PCR shows integration at the Pfmlc-b
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and then the supernatant was incubated with GFP-Trap-aga-
rose beads (Chromotek) for 2 h at 4 °C with end-over-end rota-
tion. The beads were washed extensively with 150mMNaCl, 10
mMTris, pH7.5, and then subjected to a furtherwash in 300mM
NaCl, 10 mM Tris, pH 7.5. Finally the beads were resuspended
in 5 volumes of 2 SDS-PAGE sample buffer and boiled for 5
min prior to fractionation of the proteins by SDS-PAGE.
Western Blotting—Cell lysates were separated under reduc-
ing conditions on NuPAGE gels (Life Technologies, Inc.). Pro-
teins were transferred to nitrocellulose and blocked in 5% w/v
nonfat milk in PBS 0.2% Tween 20. Primary antibodies were
diluted in 5%w/v nonfatmilk in PBS 0.2%Tween 20. Species-
specific horseradish peroxidase-conjugated secondary anti-
bodies (Bio-Rad) were used, and the signal was developed using
enhanced chemiluminescence (GE Healthcare). Blots were
exposed to BiomaxMR film (Eastman Kodak), and images were
prepared for publication using Adobe Photoshop.
Protein Identification by LC-MS/MS—Proteins were run 4
mm into a 10% NuPAGE BisTris gel (Life Technologies Inc.)
and then excised using a clean scalpel blade. Proteins were
reduced and alkylated prior to overnight trypsin digestion. The
resulting digests were analyzed by LC-MS/MS using an Ulti-
mate 3000 nanoRSLC HPLC, equipped with a 50-cm 75-m
Acclaim Pepmap C18 column, coupled to an LTQ Orbitrap
Velos Pro equipped with a Nanoflex electrospray source (all
Thermo Scientific). A gradient of 6–32% acetonitrile, 0.1% for-
mic acid over 48 min was used at a flow rate of 0.3 l/min. The
Orbitrap was operated in data-dependent acquisition mode
with a survey scan at 60,000 resolution and up to the 10 most
intense ions selected for MS/MS. Raw files were processed
using Proteome Discoverer 1.3 (Thermo Scientific) with Mas-
cot 2.4 (Matrix Science, UK) as the search engine against the
appropriate protein database. A decoy database of reversed
sequences was used to filter the results at a false detection rate
of 1%. Proteins that were represented by three ormore peptides
in the MyoB-GFP or MLC-B-GFP datasets but were absent in
the corresponding 3D7 dataset were included in further
analyses.
Bioinformatic Analyses—Alignment of sequences was per-
formed using a progressive alignment algorithm (24) within
CLC Sequence Viewer 6 (CLC Bio). Phylogenetic tree con-
struction was performed using CLC Sequence Viewer 6, using
the neighbor joining method (25) and 100 replicates for boot-
strap analysis. Coiled-coil prediction was performed using
MARCOIL and Scorer 2.0 (26, 27). A structural model of
PfMLC-B calmodulin (CaM)-like domain (amino acids 508–
645) was constructed using Phyre 2 protein fold recognition
server (28). Amino acids 508–645 were modeled on the CaM
moiety of a GFP/M13/CaM fusion protein (Protein Data Bank
code 3evr) with 97.6% confidence. Images were prepared using
CCP4 Molecular Graphics software (29).
Cloning and Expression of RecombinantMLC-B Fragments—
RNA was prepared from late P. falciparum schizonts (45 h
post-invasion) using TRIzol (Life Technologies, Inc.), and
cDNA was made from this using the reverse transcription sys-
tem with oligo(dT) primers (Promega). The primer pair 27 and
28 was used to amplify the 3 471 bp ofmlc-b, and primer pair
35 and 36 was used to amplify nucleotides 901–1227 from the
cDNA. These fragments were cloned into the BamHI and XhoI
sites of pGEX6P1 (GE Healthcare). The plasmids were trans-
formed into BL21 Gold cells (Stratagene), and protein expres-
sion was induced by the addition of 1 mM isopropyl -D-1-
thiogalactopyranoside for 3 h at 37 °C forMLC-BCTD or 18 °C
for MLC-B amino acid residues 301–409. The cell pellet was
lysed overnight at 4 °C in 20 mM Tris-HCl, pH 8.0, 250 mM
NaCl, 0.5 mM tris(2-carboxyethyl)phosphine (TCEP), and 2
mg/ml lysozyme (Sigma). The supernatant was incubated with
glutathione-Sepharose 4b resin (GE Healthcare) for 2 h at 4 °C,
followed by extensive washing with 20 mM Tris-HCl, pH 8.0,
250 mM NaCl, 0.5 mM TCEP. The beads were resuspended in 3
volumes 20mMTris-HCl, pH 8.0, 100 mMNaCl, 0.5 mM TCEP,
4 units/ml PreScission protease (GE Healthcare) and incu-
bated, with mixing, overnight at 4 °C to cleave theMLC-B frag-
ment from the GST moiety. The supernatant containing the
cleavedMLC-B fragment was collected and concentrated using
a Vivaspin20 concentrator with a 5-kDa molecular mass cutoff
(Sartorius). For MLC-B CTD buffer exchange into PBS was
carried out on a PD10 column (GE Healthcare).
Biophysical Analysis of MLC-B CTD and Its Interaction with
MyoB Neck Peptides
Peptides—Myosin B peptides 763ITSALIMKIKKKR775 and
780NIKNLQLAQAYFRKYKYIKEH800 were synthesized and
purified as described elsewhere (30). The N termini of both
peptides were acetylated, and the C termini were capped with
an amide to remove the unnatural charge.
Far-UV CD—Far-UV CD spectra were recorded on a Jasco
J-815 spectropolarimeter fittedwith a cell holder thermostatted
by a CDF-426S Peltier unit. To monitor peptide binding, CD
measurements were made at a protein concentration of 9.1 M
PfMLC-B CTD (0.17 mg/ml) and 27 M peptide (0.04 mg/ml
Ile763 to Arg775, and 0.07 mg/ml Asn780 to His800) in 25 mM
Tris-HCl, pH 8.0, 50 mM NaCl using fused silica cuvettes with
1-mm path length (Hellma, Jena, Germany). Far-UV CD spec-
tra of PfMLC-B fragment 301–409 were obtained at a protein
concentration of 11M (0.15mg/ml). All spectrawere recorded
with 0.1 nm resolution and baseline-corrected by subtraction of
the buffer spectrum. Secondary structure content was esti-
mated using methods described by Sreerama and Woody (31).
Thermal Unfolding—Thermal unfolding curves were ob-
tained bymonitoring the ellipticity at 222 nm using 2-mm path
length cuvettes and a heating rate of 1 °C/min over the temper-
ature range 20–90 °C. The transition mid-point temperature
was obtained by fitting data to the modified Gibbs-Helmholtz
equation using in-house software as described elsewhere (32).
RESULTS
MyoB Is Located at the Extreme Apical End of Merozoites,
Ookinetes, and Sporozoites, the Invasive Stages of the Malaria
Parasite—To establish the subcellular location of MyoB we
generated transgenic lines in three different parasites, P. falcip-
arum, P. knowlesi, and P. berghei, fusing MyoB to either a GFP
or a triple HA tag. P. falciparum and P. knowlesi were used to
examine MyoB expression during the asexual blood stage, and
P. berghei was used primarily to look at expression in the mos-
quito stages and in the liver stage of the life cycle.
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For P. falciparum, we used single crossover homologous
recombination to integrate sequences into themyob locus and
express the endogenous MyoB with a C-terminal GFP. Correct
integration was confirmed by Southern blotting, diagnostic
PCR, and protein expression (Fig. 1). Live parasite microscopy
was used to examine expression of MyoB-GFP during the par-
asite’s asexual blood stage development in the red blood cell. Up
until 38 h after invasion, when each schizont has 8–10 nuclei,
there was no clear green fluorescence signal detected. MyoB-
GFP expression as a distinct dot was first observed when each
schizont had 10 or more nuclei, corresponding to40 h post-
invasion (Fig. 4A). This clear pattern persisted following cyto-
kinesis and formation of mature segmented schizonts at 42–44
h after invasion and was also present in merozoites (46 h).
These data indicate that MyoB-GFP is synthesized very late in
schizont development, starting just before segmentation, and
the protein is located in a single site within each merozoite, at
the anterior end of the cell. This is also clearly apparent when
looking at P. knowlesi schizonts where endogenous MyoB
has been tagged with a triple HA tag at its C terminus (Fig. 2).
Because of the larger size, smaller number, and ordered
“apex-outward” arrangement of the P. knowlesi merozoites,
MyoB-HA can be clearly identified at the apical end of the par-
asite (Fig. 4B), similar to the pattern seen for PfMyoB-GFP.
In P. berghei, MyoBwas present in all of the invasive stages of
the life cycle. Expression was detected by quantitative RT-PCR
with mRNA prepared from six key stages of parasite develop-
ment (Fig. 2D). MyoB expressed from the endogenous locus
was tagged with GFP, using a single crossover recombination
strategy (Fig. 2E), and integration of the GFP sequence was
confirmed by diagnostic PCR (Fig. 2F). Protein expression in
schizonts was confirmed byWestern blotting (Fig. 2G). Protein
expression and location within the cell were examined by live
fluorescence microscopy. We detected MyoB-GFP as a dis-
tinct single dot in developing merozoites within schizonts,
ookinetes, and sporozoites, with the fluorescence concentrated
at the extreme apical end of the cell in each of these forms of the
parasite (Fig. 4C). In salivary gland sporozoites, in addition to
the bright apical spot of fluorescence, we also observed a more
diffuse fluorescence within the body of the parasite. This was
not observed in any other stages, and the significance, if any, of
this is unknown. In addition, in mature liver-stage schizonts
55 h after invasion by sporozoites, individual merozoites dis-
played an apical dot localization for PbMyoB-GFP (Fig. 4D).
The protein was absent in late schizonts (48 h after invasion;
data not shown).
To establish more precisely the location of MyoB-GFP
within the blood stage schizonts of P. falciparum, its position
relative to protein markers of known apical structures such as
the microneme and rhoptry organelles was examined using an
indirect immunofluorescence assay (Fig. 5). These proteins
included the microneme marker EBA175, the rhoptry bulb
marker RAP1, the rhoptry neck marker RON4, and tubulin.
Antibodies to GFP produced a compact discrete dot pattern of
fluorescence located at the very apical end of the MyoB-GFP
parasites, close to the localization of the apical markers
EBA175, RON4, and RAP1. However, although in some cases
the fluorescent signal partially overlapped with these markers,
MyoB appeared to be in a distinct location within the cell.
Examination of the localization suggested that the protein is
anterior to the microneme marker, the rhoptry bulb, and even
to the rhoptry neck. Partial colocalization with antibodies
against tubulin in merozoites suggested that MyoB-GFP was
coincident with or very close to the microtubule organizing
center at the apical polar rings from which microtubules
originate.
MyoB Does Not Relocate during Erythrocyte Invasion—The
apical location of PfMyoB-GFP suggests that it might be
involved in erythrocyte invasion in merozoites and perform a
similar function in the other invasive stageswithin the life cycle.
Therefore, we examined the location of the protein during inva-
sion relative to RON4, which can be traced by indirect immu-
nofluorescence assay from a single point close to the apex of the
merozoite during attachment and through to completion of
entry and formation of the parasitophorous vacuole (PV) (23).
In free merozoites, PfMyoB-GFP is located at the anterior end
of the cell, apical to RON4 (Fig. 6, row 1). At the initial attach-
ment, there is a partial colocalization of PfMyoB-GFP with
RON4 (Fig. 6, row 2). Then, as themerozoite starts the invasion
process (Fig. 6, rows 3 and 4), RON4 is located anterior to
PfMyoB-GFP, suggesting the secretion of RON4 from the rhop-
try neck onto the host cell. As the parasite finishes invading the
erythrocyte, RON4 is localized at the posterior of the parasite,
andMyoB-GFP remains at the apical end of the cell (Fig. 6, row
5). RON4 then becomes delocalized in the remnants of the
junction, which has closed the developing PV and plasmamem-
brane and spreads in patches around the expanding PV mem-
brane, suggesting loss of structural integrity of the junction at
this stage, although PfMyoB-GFP remains as a single dot (Fig. 6,
rows 6 and 7). During early ring stages, PfMyoB-GFP remains as
a single dot located inside the PV membrane (Fig. 6, row 8).
Because MyoB-GFP cannot be detected in trophozoite stages
(see above), it is likely that after invasion has been completed
PfMyoB-GFP is eventually degraded.
MyoBDoesNotAssociatewithComponents of theGlideosome
Complex—AlthoughMyoB is overall similar in size and domain
structure to MyoA (1, 2), the localization data suggested that it
occupies a very different compartment of the merozoite to that
ofMyoA.Nevertheless, these data donot exclude the possibility
that it is associated with components of the glideosome, and
therefore, we examinedwhether or not known glideosome pro-
teins were bound toMyoB-GFP immunoprecipitated frompar-
asite extracts. Mature P. falciparum schizont-stage parasites
expressing MyoB-GFP were enriched and solubilized in buffer,
and then proteins were immunoprecipitated with anti-GFP
camelid nanobodies coupled to agarose beads. The precipitated
proteins were then resolved by SDS-PAGE and subjected to
Western blot analysiswith antibodies specific to components of
the glideosome. As controls, similar extracts were made from
the parental 3D7 line and a parasite line expressingMyoA-GFP
that had been produced in the same way (Fig. 1).
A GFP-specific monoclonal antibody (mAb) detected bands
corresponding to PfMyoA-GFP and PfMyoB-GFP (both 120
kDa) in the respective lysate and immunoprecipitate but not in
lysates from 3D7 parasites (Fig. 7). The relative intensity of the
bands in the two parasite samples indicated that PfMyoA-GFP
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ismuchmore abundant than PfMyoB-GFP, as an equal amount
of total parasite protein was loaded in each case. The MyoA-
GFP immunoprecipitate containedMTIP, GAP45, andGAP50.
However, none of these glideosome complex proteinswere pre-
cipitated with PfMyoB-GFP, demonstrating that MyoB does
not form a complex with known components of the MyoA
glideosome.
Identification of a MyoB Protein Complex, Including a Puta-
tiveMyosin Light Chain—To establish whether or not PfMyoB-
GFP formed a complex with unknown proteins, the PfMyoB-
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FIGURE 4. MyoB subcellular location in asexual blood and mosquito stages. A, microscopic analysis of live P. falciparum asexual blood stage parasites
expressing GFP-tagged MyoB. Shown are blood stage parasites of increasing maturity from early schizogony (two to four nuclei; 30 h post-invasion) through
tomature segmenter forms (44 h post-invasion) and freemerozoites analyzed by fluorescencemicroscopy. GFP was detected by green fluorescence, and the
nuclei (blue) were labeled with Hoechst dye prior to microscopic analysis. GFP fluorescence was not detected in trophozoites (data not shown) and early
schizont stages, and was first apparent in mature multinucleate schizonts as a number of single dots (40 h post-invasion). Following cytokinesis, a single dot
waspresent associatedwith eachnucleus atwhat appeared tobe the apical endof the cell. The images,mergedwith thedifferential interference contrast (DIC)
image, are shown in the right panel. Scale bar, 2 m. B, immunofluorescence of MyoB-HA in P. knowlesi schizonts. The epitope is detected using a specific
antibody and an AlexaFluor 488 secondary antibody. Nuclei are labeled with DAPI; the green, blue, and differential interference contrast-merged images are
also shown. Scale bar, 2 m. C, expression of MyoB-GFP in the three invasive stages: schizonts (merozoites), ookinetes, and sporozoites of P. berghei. GFP is
detectedbygreen fluorescence, andnuclei (blue)were labeledwithHoechst dye. Themergedanddifferential interference contrast images are also shown. The
white arrows indicate expressionofMyoB-GFP at the apical endof theparasites. Scale bar, 5m.D, expressionofMyoB-GFP in liver stage schizonts of P. berghei,
55 h after invasion by a sporozoite. GFPwas detected by green fluorescence, and the nuclei (blue) were labeledwith Hoechst dye prior tomicroscopic analysis.
Merged images are shown in the right panel. Scale bar, 10 m. E, schematic showing the three invasive stages of Plasmodium, merozoite, ookinete, and
sporozoite. The approximate length from anterior to posterior is shown.
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GFP purified in the previous immunoprecipitation was
resolved by SDS-PAGE, and proteins were identified following
trypsin digestion and peptide analysis by LC-MS/MS. An iden-
tical immunoprecipitate from the lysate of wild-type 3D7 par-
asites was used as a control. A total of 11 proteins (each repre-
sented by more than two peptides) was identified in the
PfMyoB-GFP precipitate and absent from the control (proteins
are listed in Table 2). MyoB was represented by 40 peptides.
None of the proteins from the glideosome complex (MyoA,
MTIP, GAP45, andGAP50) were identified in this dataset, con-
firming theWestern blot analysis of the precipitate presented in
Fig. 7. Of the remaining 10 proteins, only two were represented
by more than five peptides: PF3D7_1118700 (six peptides;
11.7% coverage), described as a “conserved Plasmodium pro-
tein of unknown function,” and Pf3D7_1211700 (seven pep-
tides; 11.9% coverage), described as a putative minichromo-
some maintenance subunit 5. Although MCM5 seemed an
unlikely MyoB partner because of its predicted location in the
nucleus, PF3D7_1118700 encodes a predicted EF-hand con-
taining domain at its C terminus, reminiscent of that present in
other myosin light chains such as MTIP. The remaining pro-
teins identified using this approach included polyubiquitin,
SEC31, acyl-CoA synthetase, and a putative clathrin heavy
chain.
The PF3D7_1118700 gene is 4.3 kb, with 18 exons, and in P.
falciparum 3D7 asexual blood stages expression of the gene
peaks in the late stage of schizogony, 41 h after invasion (33).
The protein product is predicted to be 652 amino acids, with a
molecular mass of 78.7 kDa; hereafter, we will refer to it as
myosin light chain B (MLC-B). The protein is well conserved
among all Plasmodium species for which sequence information
is available (a phylogenetic tree and alignment of Plasmodium
MLC-B proteins are shown in Fig. 8, A and B). The MLC-B C
terminus (residues 508–645) resembles sequences from the
EF-hand superfamily (Interpro: IPR011992) such as CaM and
CaM-like calcium binding domains, which are also a feature of
myosin light chains. We used the Phyre 2 protein fold recogni-
tion server (28) to create a structural model of the CaM-like
domain of MLC-B. This shows a compact molecule that forms
a structure with a channel through the center (Fig. 9A). We
would expect the protein to form a clamp around an interacting
peptide in an analogous manner to that described for CaM
binding to the M13 peptide of myosin light chain kinase, the
structure uponwhich this domain ofMLC-Bwasmodeled (34).
Using the C-terminal CaM-like domain to perform BLAST
analysis on theToxoplasma gondii genome, most of the hits are
small CaM or CaM-related proteins. One large protein of 885
amino acids was also identified, TGME49_250840, and anno-
FIGURE 5.PfMyoB-GFP is located at the apical pole of themerozoite. Indi-
rect immunofluorescence of PfMyoB-GFP (green) with various merozoite
organelle markers (red), using antisera to row i, EBA175; row ii, RAP1; row iii,
RON4; and row iv, -tubulin (TUB). Samples were counterstained with DAPI
(blue). The merged images are also shown. Rows i–iii show individual schiz-
onts, and row iv shows an individual merozoite. Scale bar, 2 m.
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FIGURE 6. PfMyoB-GFP remains at the anterior of the merozoite during
invasion of the host cell.MyoB-GFP-expressing P. falciparum parasites were
fixed during various stages of invasion, and then MyoB-GFP (green) was
revealed using rabbit anti-GFP antibodies, RON4 (red) was detected using
mAb 24C6, and nuclei were stained with DAPI (blue). Merged images, includ-
ing the differential interference contrast, are shown, as well as a schematic of
the invasion stage in which the moving junction is shown by the blue arrow-
heads, the extracellular merozoite is gray, and the intracellular parasite is
denoted by a dotted line and is uncolored. The invasion steps have been
divided into initial attachment, followed by early and late stages of invasion
as well as the final steps of invasion with the release of the remnant junction
and formation of the ring stage. Scale bar, 2 m.
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tated as a “hypothetical protein.” This protein is predicted to
have the same overall domain structure as PfMLC-B, with a
CaM-related domain at its C terminus and extensive predicted
coiled-coil domains, and it has the attributes needed to be the
orthologue of MLC-B in T. gondii.
MLC-B and MyoB Have the Same Subcellular Location and
FormaComplex—To establish furtherwhether or not the puta-
tive MLC-B is in a complex with MyoB in the cell, we first
generated a P. falciparum parasite line that expresses MLC-B
with GFP at its C terminus and a P. knowlesi parasite line that
expressesMLC-B with a triple HA epitope tag at its C terminus
(Fig. 3).
P. falciparumMLC-B-GFPwas localized by live fluorescence
microscopy to the extreme apex ofmerozoites (Fig. 9B, panel i),
with expression restricted to those schizonts containing 10 or
more nuclei, as was also the case for MyoB (Fig. 4A). Similarly,
P. knowlesiMLC-B, identified by an antibody to the HA-tagged
protein, could be clearly seen as a discrete dot at the very tip of
the elongated merozoite within segmented schizonts (Fig. 9B,
panel ii). Immunofluorescence showed a complete colocaliza-
tion ofMLC-B-GFP andMyoB in P. falciparum schizonts, with
the proteins located at the apical tip of each merozoite (Fig. 9B,
panel iii).
To confirm an in vivo interaction between MLC-B and
MyoB, and to establish the identity of any other proteins that
may bind to MLC-B, we immunoprecipitated MLC-B-GFP
from extracts of late schizonts and analyzed the precipitated
proteins by LC-MS/MS using identical methodology as for
PfMyoB-GFP. A list of proteins present in the MLC-B-GFP
immunoprecipitate but absent in a control 3D7 precipitate was
constructed (Table 3) and compared with theMyoB-GFP data-
set (Table 2). Only two proteins were present in both theMLC-
B-GFP and MyoB-GFP precipitates, MyoB and MLC-B (Fig.
9C). Overall, these data indicate that MLC-B and MyoB have
the same subcellular location and form a protein complex
within the parasite, consistentwithMLC-Bbeing amyosin light
chain specific for MyoB.
Calmodulin-like Region ofMLC-B Binds to the C Terminus of
MyoB—The similarity of the C terminus of MLC-B to the EF-
hand superfamily suggested that the interaction between
MLC-B and MyoB may be mediated by binding of the calmod-
ulin-like C-terminal domain (CTD) of MLC-B to the neck
region of MyoB. This is analogous to the interaction between
MTIP and MyoA (7, 35).
To study the MLC-B CTD in more detail, we expressed the
C-terminal 156 amino acids, (residues 497–652) in Escherichia
coli and purified the protein to homogeneity by affinity chro-
matography. Initial analysis of the overall structure of the pro-
tein was performed using far-UV CD (Fig. 9D, panels i and ii,
red line). Comparing the spectrum of MLC-B CTD with those
of reference proteins predicted that it contained 40% -helix,
14% -sheet, 17% turn, and 27% unordered structure. There
was no change in the CD spectrum upon the addition of cal-
cium to 1 mM (data not shown), indicating that an interaction
with calcium was unlikely.
We next tested the ability ofMLC-BCTD to bind to peptides
from the C terminus of MyoB. Using far-UV CD, we looked for
changes in the spectrum ofMLC-B and peptide that may occur
FIGURE 7. PfMyoB-GFP does not associate with the glideosome compo-
nentsMTIP,GAP45, andGAP50. i,Westernblot of parasite lysates from3D7,
MyoA-GFP (A), andMyoB-GFP (B) parasite lines. ii, GFP-TRAP immunoprecipi-
tates fromcorrespondingparasite lysates (shown in i) separatedbySDS-PAGE
and probed with antibodies indicated on the right of each panel (rabbit anti-
GFP, anti-GAP50, anti-GAP45, and anti-MTIP). Although GAP50, GAP45, and
MTIP were present in all the lysates, they were detected in the MyoA-GFP
immunoprecipitate but not in the MyoB-GFP immunoprecipitate. Molecular
mass markers are indicated on the left in kDa.
TABLE 2
Analysis of MyoB-GFP bymass spectrometry following immunoprecipitation from a parasite lysate
Each protein identified is listedwith their PlasmoDB accession number, a description of the protein identified, and themolecularmass. The 4th column gives the percentage
of the protein sequence covered by the identified peptides, and the number of unique peptides detected is in the 5th column.MyoB and its light chain are highlighted in blue.
PlasmodiumMyoB Is Apical, with a Large Atypical Light Chain
MAY 8, 2015•VOLUME 290•NUMBER 19 JOURNAL OF BIOLOGICAL CHEMISTRY 12157
 at LO
N
D
O
N
 SCH
 O
F H
Y
G
IEN
E &
 TRO
PICA
L M
ED
ICIN
E on M
ay 3, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
upon binding between the two. Fig. 9D, panels i and ii, shows
the overlaid spectra of MLC-B CTD (red), the peptide alone
(blue), the calculated sumof theMLC-BCTDandpeptide spec-
tra (black), and a solution of MLC-B CTD and peptide (green).
For a control peptide that spans residues Ile763 to Arg775 of
MyoB, the peptide spectrum is characteristic of a random coil,
MKV L KT SKNN F VH PN K SNQYN CND - - - - - Q PYD S L F RKN CV S F Y ED FD T EA I F L LD KG SR P I YH K L K - - - - - - D K EWG S S
M E I L KG SVN K I VN T Q - R S P L SYDDD - - - GK P F S S L F RKN RV S F YDD L RT EAV L L LWKN SHH PKY F AY V T N F R I N R ECV L F
M E I L KG SV SK F VH T QKRN P L SYDDDDDDGK P F S S L F RKN RA S F Y ED L RT EAV L L LD KG S E P I N Y E L - - - - - - I D R ECV L F
MD - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - N F P P P S L S SY V T N F R I N R ECV L F
M- - - - - - I QN L Y V PQNN K I KN YN E - - - - - RKT T S L F RNN SV S F YND VN T EA I C L LD RAT Q P I N Y K I - - - - - - I KND C I L F
M- - - - - - I QN L Y T PQNN K I KN YN E - - - - - KKT T S L F RNNAV S F YND VN T EA I F L LD RAT Q P I N Y KM- - - - - - I KND CV L F
M- - - - - - I QN L Y T PKNN K I KN VN E - - - - - RKN T S L F RNN SV S F YND VN T EA I S L LD RAT QQ I D YNM- - - - - - I KND C I L Y
NNQKD T EKKKKK E - - - - - - - - - - - - - - - - - - - - - - - - - E F EK I D E I I SNA EH LNN L RN K L Y S F EYQN I L E P L G I Y I SQQ E
SQGKQ I RH I RKKQV L L I MRKG F PQ L V L VNM F S L L R L R E E F EK I ND I LN S I D Y LD T L K EKVHD RN V EK I I E P L G I - CA PR E
SQGKQ I RH T RKKQ - - - - - - - - - - - - - - - - - - - - - - - - - E F EK I N E I I NN I D Y LD T L K EKVHN RN L EK I V E P L G I - CA PR E
SQGKQ I RH T RKKQ - - - - - - - - - - - - - - - - - - - - - - - - - E F EK I ND I I NN I D Y LD T L K EKVHD RN V EK I V E P L G I - CA PR E
KDGN K I QH T KK EK - - - - - - - - - - - - - - - - - - - - - - - - - E FD K I T Q I VNA SN Y LN S L K SK I H T T D I EQ I T K P L G I Y F SN EK
K EGN K I QH T KK EK - - - - - - - - - - - - - - - - - - - - - - - - - E FD K I T Q I VND AD Y LN S L K SK I H T T D I EK I T K P L G I Y C SN EK
KDGN KNQH T KK EK - - - - - - - - - - - - - - - - - - - - - - - - - E F EK I T K I VND AD Y LN S L K SK I H T T D I EK I T Q P L G I Y S SK EK
D K E EN I KR EMGN F - Y KD EY E I L KKKY I H L K ENMD T I LD V ER I KAGL F Y T K ED LQK I F E I I RKHQ SK I NN KND I I K FQ S SM
G I PKG SGE EYGE L T Y KD K F EVMKN KYND L KKNMD T R I H L E L I KAGV F YNQDD I QN V LHMV RKYQGD L KT KK S I I N VQNG I
G I PQG SDGEYGD L T Y KD K F ET L K SKYDD L KKN LD T R I H L E L I KAGV F YNQ ED I QN V LHMV RKYQGD L KT KKR I I N VQNG I
G I PKG SDGEYGE L T Y KD K F EA L KN KYDH L KKN LD T R I H L E L I KAGV F YNQDD I KN V L YMV RKYQGD L KT KK S I I N VQNG I
S- - N S L RT KDND L V Y KN KY E S L KK EYDN L K ERMD I K I D L E L I KAGA F YN K ED I HD I L R L I KKYQ SR I K EKKD I I D T QNN V
S- - N S L GAKDND V I Y KN KY E S L KK EYDN L K ERMD I K I D L E L I KAGA F YN K ED I HD I L R L I KKYQ SR I K EKKD I I D T QNN V
S- - N SH RAKYND I I Y KN KY K S L KK EYDD L K ER I D I K I D L E L I K SGA F YN K ED I HD I LH L I KKYQ SK I K EKKD I I D T QNN V
L EKA I EHN KKN K L T I I KD KRKN EK L L E I CK SY Y EQN EKAQKK L RH L KY S F L EY K I A L EN I V SCC EK I GGD K I I LMDG I K S
I QN V V ERN K L SRN K L R LD K EKN EGLMKMCRT Y Y EQN KN T QMR L RK L KHA F L EY K I A L E S I V SCC EK I GGD K I I LMD V V K S
I QN V V ERN K L SRN K L L VD KRKN E E LMKMCRT Y Y EQ SK SAQ L R L RK L KHA F L EY K I A L E S I A SCC EK I GGD K I I LMD AV K S
I QN VM ERN K L SRN K L L VD KKKN E E LMKMCRT Y Y EQN K SAQT R L RK L KHA F LQY K I A L E S I V SCC EK I GGD K I I LMD AV K S
I EN I M EQT K LN RN K F I V EKKKN EDMAK I CH SY Y RQ SKKT QMKMKM L KY S F L EY KMA L EN I V SCC EQ I GGD K I I LMD A I K S
I EK I M EQT K LN RN K F V V EKKKN EDMT K I CN SY Y RQ SKKNQMKMKM L KY S F L EY KMA L EN I V SCC EQ I GGD K I I LMD A I K S
I EN I M EQT K LN RN K F I V EKKKN EDMAK I CN SY YHQ SKKT QMKMKM L KY S F L EY KMA L EN I V SCC EQ I GGD K I I LMD A I K S
ARAQADM S I AND I KN K I K I E E L EMN I SY C EQQ I N Y L KDD LD F KM E E L RN T T L Y T E EV KN EA SY F KQ E L SKNND L L L EVM E
ARAQT D L S I AT D I LN T KK I Q E L EMN I CY C EHQ I N S L KDD LD TM L AK LQD EKK EKR EVMNQA LQY K EH L AKNNDM L I EA L E
ARAQT D L S I AT D I LN T KK I Q E L EMN I CY C EHQ I N S L KDD LD AM L GK LQN EKK EKR EVMNQT L RY K EH L AKNNAM L I EA L E
ARAQT D L S I AT D I LN T KK I Q E L EMN I CY C EHQ I N S L KDD LD VM L GK LQN EKK EKR EVMNQT L RY K EH L EKNNAM L I EA L E
AKT QT D L S I AT E I LN I KK I KD L EM S I CY C EHH I N Y LN E E LN L K LQ E L KN ET K EKK EAQN E I Y SY KK E L T KNNNM I I K I L E
AKT QT D L S I AT EM LN I KK I K E L EM S I CY C EHH I N Y LN E E LN L K LQ E L KN ET K EKK EAQN E I Y SY KK E L T KNNNM I I K I L E
AKT QT D L S I AT EM LN I KK I K E L EM S I CY C EHH I N Y LN E E LN L K LQ E L KNAAK EKK ET QN E I Y SY KK E L AKNNNM I I K I L E
H FHQM I NN VD E F I Y KN KD KN - - E L I T YMN KKKKKYGD I T KK I S EKN K E LN L KV KN F V PYN F SMGT E L KKH E EY L K I QMD E
N F RRVM I SVD EH L SR E SD R S- - D F KKT FDN SKKKYND F V RKAAV KN K E LQKMGD K L I LMNA L SGQ E L KKHQ EY LN RQ I NQ
N F RRVMT SVD EH L SR EGGR S- - D F K ET FD K SKKKYND F V RKAA EKN KD LQKMGD K L L L A SA L SGR E L KRHQ EY LN RQ I K E
N F RRVMT SVD EH L SR EGN R S- - D F K ET FD K SKKKYND F V RKAA EKN KD LQKMGD K L L L T SA L SGH E L KRHQ EY LN RQ I N E
N YHQMMATM EK I I Y END I AN - - KY K PD F I KD KKKYNDMV K L L L E SN K E L KN I ND K L F L SNN V F KGK L KNHQ E F L T KHMN E
F YHQMMV TM EK I I YDNDNNN - - KY K PD F I KD KKKYN E L V KK I L E SN K E L K SGND K L F L SNN V F KGK L KNH K E F L T KHMN E
D YHQTMATM EK I I Y ENDNANAN KH KT D F I KD KKKYND L V KKV L E SNN E L KNNND K L F LHDN V L KGK L KAHQ E L L T KHMN E
MKKK - - - - - - - E E E EKRKRR E E E E E EQKKRK E E E E E EQKKRK E E E EK I EKKKK E E E E EKRKK E EQ E L L E EKD I KNN ET F E
I RKNQGG I E - - E E EQKGN KNNGKV GEV EKGNQ E E EQDQKQT L EGK SC - QGV KD I PND I EGKQGK EK - - E EQT KRVD E S L E
I RKN EG I V EGGE E EQKGH KN RGKV GD A EKG SHA E EQD K EQ P L EGE S S SQGAK E I AND A EGK EAKQK - - GEQ PT H VD EN L E
MKKNQGGV E E - E E EQKGH KNGGKV GEA EK S SH E E EQD KKQ P L EGE S S- QGAK E I T ND T ERKQA EQK - - GEQ PT H VD E S L E
DN KN - - - - - - - - - - - - - - KH KDD AN K I SN L T DQT N ET KN I D K S ET E I I AK ENN ST N ET V L KN - - - - - - - - - - - N I D I N V E
DN KN - - - - - - - - - - - - - - KH K ED VN K I SN L ANQ I N ET KN I N K S ET E I I PK ENN ST N EN E PKN - - - - - - - - - - - N I D VN V E
- - - H - - - - - - - - - - - - - - K PK EAVN KA P S L ADQKN ET ENAD K P ET GVMGN ENN ST N EV E PKD - - - - - - - - - - - NQD I PVD
EKK I R L V K E LMK EVN E ET L S L EKCVD I I Y KAN L P L T QN K LN K L KNMGD I KKD E L V T F V KT LM LN EQ EA F ENMKT F F E I WD
GR I I NQVM E L LQKK ENN K L T F ED CVD V I Y KVN L P L T Q SK LN E L KAMGEVD K ED L I A F I KT F I MD ED EA LQNM I T F F E I WD
GRK I NQVM E L L KKK E I D R L T F ED CVD V I Y KAN L P L T Q SK LN E L KAMGEV RKDD L V A F I KT F I MD ED EA LQNM I T F F E I WD
GRK I NQVM E L LQKK E I D K L T F ED CVD V I Y KVN L P L T Q SK LN E L KAMGEVH KDD L V A F I KT F I VQ E E EA LQNM I T F F E I WD
LD K I EK I Q E F I KN KN I D K L K F ED CVD I MY K SN I V L T RN KM E E L KQMGL I T AN E F V T F I K P F I I N E E EA L KNM I T F F E I WD
L EK I EK I QQ L I KD KN I D K L K F ED C LD I MY K SN I V L T RN KM E E L K EMG S I GAN E F V T F I K P F I I N E E EA L KNM I T F F E I WD
L EK I EK I Q E F I KN KN VD K L K F ED C LD I MY K SN V V L T R SKM E E L KQMD P I T T D E F V T F I K P F I I N E E EA L KNM I T F F E I WD
I MKT GYMH KN L I I S I L KQ FGDN L T E E E SN Y I QK E LNQM S E SN I SY V K L L KKW I YGT E E - -
VQKT GYMH K E L I L L I L KQ FGD K L T ED EM EY L RGEVNA F K E SN I SY VD L L KRW I QGT GE - -
VQKT GYMH K E L I L L I L KQ FGD S L T ED EM EY L RGEVNA F T E SN I SY VD L L KRW I QGA E E - -
VQKT GYMH K E L I L L I L KQ FGD S L T ED EM EY L R- - - - - - - E SK - - - - - - KKR- - - - - - - - -
V KKT GYMH KD L FM P I L KY FGDH L SDQ E I D Y LQK E LN L SN E PK I SY AD I L KKW I YGKDQQ I
V KKT GYMH KD L FM P I L KY FGDH L SDQ E I D Y LQK E I N L LN EAN I SY AD I L KKW I YGKDQQ I
V KKT GYMH KD L FM P I L KY FGDH L SDQ EMD Y LQK E L S L SN E PN I SY VD I L KKW I YGKDQQT 0                     100%
conservation
FIGURE 8. Myosin light chain B phylogeny, structure, and expression. A, phylogenetic tree with relationship between MLC-B sequences in Plasmodium
species. The treewaspreparedusing the alignment shown inB. Theneighbor-joiningmethodwasused,with 100 replicates used togenerate bootstrap values,
which are indicated at the branch points. The tree is drawn to scale, with branch lengths indicating the amount of variation (scale bar, 0.3 amino acid
substitutions per site). B, alignment of PlasmodiumMLC-B proteins. In PlasmoDB: P. knowlesi PkMLC-B, PKH_091610; Plasmodium vivax PvMLC-B, PVX_091570;
Plasmodium cynomolgi PcyMLC, PCYB_092480; P. berghei PbMLC-B, PBANKA_092940; Plasmodium. yoelii PyMLC-B, PY17X_0931400; Plasmodium chabaudi
PcMLC-B, PCHAS_091490. Regions of PfMLC-B predicted to form dimeric coiled-coil structures are marked with a broken line above the sequence. The cal-
modulin-like domain is marked with a solid line above the sequence.
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FIGURE 9.PfMLC-B colocalizes in the cell withMyoB, binds toMyoB in vivo, and its C-terminal domainbinds to theMyoBC-terminal sequence in vitro.
A, structural model of amino acids 508–645 of PfMLC-B. The protein backbone is shown as a green ribbon, with a space-fill model of the structure overlaid. B,
panel i,MLC-B-GFP subcellular location in aP. falciparum schizont.GFPwasdetectedbygreen fluorescence, and thenuclei (blue)were labeledwithHoechstdye
prior tomicroscopic analysis. Merged images are also shown. Scale bar, 2m. Panel ii,MLC-HA localization to the apex of merozoites in a P. knowlesi schizont.
TheHA epitopewas detected using a specific antibody, followedby a species-specific AlexaFluor 488-labeled secondary antibody. Nuclei (blue) were detected
using DAPI. Merged images are also shown. Scale bar, 2 m. Panel iii, indirect immunofluorescence of P. falciparum schizont to determine colocalization of
MLC-B-GFP (green) with MyoB (red). Nuclei were counterstained with DAPI (blue). The merged images are also shown. Scale bar, 2 m. C, analysis of proteins
affinity-purified with GFP-Trap from lysates of parasites expressing either PfMyoB-GFP or PfMLC-B-GFP by SDS-PAGE, trypsin digestion, and LC-MS/MS.
Following subtraction of the list of proteins detected in control experiments, the lists of proteins detected in the two preparations were compared. Two
proteins, MyoB and MLC-B, were in common. D, analysis of the binding of the C-terminal domain of PfMLC-B to peptides derived from the sequence at the C
terminus of MyoB by either circular dichroism (panels i and ii) or thermal unfolding in the presence of peptides based on the MyoB amino acid sequences,
residues Ile763 to Arg775 and Asn780 to His800 (panel iii). E, alignment of the neck regions of PfMyoA, PfMyoB, and TgMyoA showing confirmed (red) and
speculated (blue) light-chain binding regions.
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and there is no difference between the sum of theMLC-B CTD
and peptide spectra and that of a solution containing the two
components (Fig. 9D, panel i). This suggests that there is no
interaction between the two, although there is the possibility
that they interact without an accompanying structural change.
Fig. 9D, panel ii, shows the same analysis for a peptide from the
extremeC terminus ofMyoB. The solution ofMLC-BCTD and
Asn780 to His800 peptide (Fig. 9D, green) showed a different
spectrum when compared with the sum of the individual spec-
tra (black), indicating that they interact and that there is an
increase in -helix content in one or both of the components
upon binding.
The interaction of MLC-B CTD with the MyoB Asn780 to
His800 peptide was confirmed by performing thermal unfolding
experiments. A solution of MLC-B CTD with or without pep-
tide was subjected to progressively higher temperatures, and
the change in differential absorbance at 222 nm was measured
to track the transition of MLC-B from a folded to an unfolded
state. The presence of a strong binding partner would be
expected to stabilize a protein, necessitating an increased input
of energy for this transition to occur. Fig. 9D, panel iii, shows
the thermal denaturation profile of MLC-B CTD alone (in
black) or in the presence of MyoB C-terminal peptides as fol-
lows: a 3-fold molar excess of the Ile763 to Arg775 peptide (in
green), and a 1.5- or 3-fold molar excess of Asn780 to His800
peptide (blue and red, respectively). The presence of the Ile763
to Arg775 peptide had no effect on the thermal denaturation of
MLC-B CTD. In contrast, in the presence of a 1.5-fold molar
excess of the Asn780 to His800 peptide, the melting temperature
(Tm) of MLC-B CTD increased from 59 to 67 °C. With a 3-fold
molar excess of the Asn780 to His800 peptide, the Tm increased
to 70 °C. These results indicate a strong interaction between
MLC-B CTD and the Asn780 to His800 peptide.
Fig. 9E shows an alignment of the neck regions of PfMyoA,
PfMyoB, and TgMyoA. The regions at the C terminus where
MTIP, MLC-B, and MLC1 bind are highlighted (although for
TgMyoA the binding has been inferred rather than directly
shown; deletion of this region causes mislocalization of MyoA
in T. gondii tachyzoites (36)). All three binding regions contain
a preponderance of basic residues that for bothMyoA proteins
have been shown to be essential determinants of binding (6, 36).
It seems likely that basic residues in the MLC-B binding region
of MyoB will also be important determinants of binding.
Recently, it has been demonstrated that the TgMyoA motor
complex contains an additional light chain, designated TgELC
(37). It has been speculated that binding of the additional light
chain takes place N-terminal to the binding site of MLC1 (3),
and indeed it has been demonstrated that both light chains are
required in order for TgMyoA to achieve the maximal move-
ment of actin (38). All three of the class XIV myosins shown in
Fig. 9E have a similar amount of “free” space at the appropriate
position. It is likely that there is an additional light chain that
binds to this position in MyoB, although we did not detect a
suitable candidate in our immunoprecipitation studies (Tables
2 and 3), and due to the degeneracy of the IQmotifs in apicom-
plexan myosins, it is not possible to speculate as to the precise
binding site.
Coiled-coil Region of MLC-B—The N-terminal remainder of
MLC-B is predicted to be largely -helical. By in silico analysis
using Scorer (27) with the threshold for coiled-coil prediction
set to 99%, three regions of PfMLC-B were predicted to form
dimeric coiled-coils: regions 184–249, 301–409, and 446–501.
TABLE 3
Analysis of MLC-B-GFP bymass spectrometry following immunoprecipitation from a parasite lysate
Each protein identified is listedwith their PlasmoDB accession number, a description of the protein identified, and themolecularmass. The 4th column gives the percentage
of the protein sequence covered by the identified peptides, and the number of unique peptides detected is in the 5th column. MLC-B and MyoB are highlighted in blue.
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All three were expressed as GST fusion proteins in E. coli, but
only the largest of the three was soluble and therefore suitable
for further analysis (the 109 amino acid region from 301–409).
After removal of the GST moiety by proteolysis, far-UV CD
spectroscopy was used to assess the secondary structural con-
tent of the recombinant protein (Fig. 10A). Analysis of the spec-
trum using standard methods (32) shows that the protein is
very highly helical, i.e. composed of 70.7% -helix, 2.3%
-sheet, 11.7% turn, and 15.4% random coil. This extremely
high helicity is consistent with the prediction that the protein
adopts a coiled-coil conformation.We next assessed the behav-
ior of the protein at different concentrations in thermal unfold-
ing experiments, monitoring the unfolding by measuring the
CD signal at 222 nm.We analyzed solutions of PfMLC-B(301–
409) at three different concentrations, covering a 25-fold range
in protein concentration. The Tm of PfMLC-B(301–409)
increasedwith concentration (Fig. 10B). Thermal unfolding of a
monomeric protein should be independent of the protein con-
centration, whereas in dimeric or trimeric proteins, the Tmwill
increase with increasing protein concentration (32). We can
therefore confidently state that the region of PfMLC-B from
301 to 409 adopts a highly helical dimeric (or trimeric) struc-
ture that is consistent with a coiled coil.
DISCUSSION
We have characterized a novel class XIV myosin, MyoB in
Plasmodium. Like the other short class XIVmyosin,MyoA, this
myosin has no tail region; the catalytic head domain is followed
by a modified neck region, which for MyoA is the binding site
for a light chain that has been designated MTIP. Whereas
MyoA is part of the glideosomemachinery that powers parasite
motility and invasion, the location of MyoB in the cell was
uncertain (15). To characterize MyoB, we used three parasite
species, P. falciparum, P. knowlesi, and P. berghei, taking advan-
tage of the unique experimental opportunities they each pro-
vide. P. berghei allows stages of the life cycle in the mosquito
and in the liver to be analyzed, and there are robust systems for
genetic manipulation of the parasite. P. knowlesi has been
recently adapted to growth in vitro in human red cells; trans-
fection is highly efficient, and the merozoites are signifi-
cantly larger than those of P. falciparum and P. falciparum
for which growth in vitro can be efficiently synchronized,
and there are many reagents to identify specific proteins. We
show here that the myob gene is expressed in the motile
and invasive stages of the parasite’s life cycle: merozoite,
ookinete, and sporozoite forms. By using tagged MyoB, we
show that the protein locates to a compact and discrete api-
cal region at the very tip of these three polarized cells. This
location is distinct from that of MyoA, which is detected
around the periphery of the parasite (39). During the devel-
opment of asexual blood stages of P. falciparum, the protein
is only detected late in the cycle, when there are 10 or more
nuclei, and just before cytokinesis (segmentation) occurs to
form individual merozoites.
Colocalization studies in merozoites, using rhoptry, rhoptry
neck and micronemal markers confirmed the localization of
MyoB-GFP to the extreme apex of merozoites, anterior to all of
the organellemarkers used.We also demonstrated that its loca-
tion partially overlappedwith-tubulin. Tubulin forms the two
or three subpellicular microtubules known in merozoites as
f-MAST, anchored at the anterior polar ring and running in
parallel along the merozoite periphery toward the posterior of
the merozoite (40). The localization of microtubules has been
shown in previous studies by immunofluorescence (40, 41) and
electron microscopy (42). It is possible that MyoB is located at
the polar ring(s); however, definitive localization studies will
require immunoelectron microscopy. We have been unsuc-
cessful in this approach with both GFP- and HA-tagged para-
site lines, perhaps due to the very low abundance of the protein.
It should be noted that in P. bergheimerozoites, ookinetes, and
sporozoites in which actin filaments have been stabilized using
jasplakinolide, F-actin is detected by an antibody specific for
actin I at the apical end and periphery of the cells, suggesting
that these are sites of high actin turnover (43). We have dem-
onstrated that MyoB is present at the apical ends of these cells,
FIGURE 10. PfMLC-B(301–409) is highly helical and shows concentration-dependent thermal unfolding. A, far-UV CD spectrum of a solution containing
0.15 mg/ml PfMLC-B(301–409). The spectrum is characteristic of an extremely -helical protein. B, thermal denaturation of PfMLC-B(301–409) performed at
three protein concentrations: 0.03, 0.15, and 0.75mg/ml. Unfolding wasmonitored by observing the change in the CD signal at 222 nm. The Tm of the protein
increased with concentration, consistent with a nonmonomeric protein.
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consistent with MyoB being a motor that moves filaments of
actin I.
The location of MyoB at the apex of the three invasive stages
of the parasite life cycle suggested that it has a role in cellular
invasion. Invasion is a complex process in which reversible ini-
tial attachment is followed by the elaboration of amoving junc-
tion between parasite and host cell that moves backwards over
the parasite surface as it enters the RBC. The moving junction
can be visualized by microscopy with antibodies to the rhoptry
neck protein RON4.We examined the fate of MyoB during the
process of merozoite invasion of red blood cells and compared
it with RON4. Although initially anterior to RON4, MyoB
remained static as RON4 moved to the apex of the merozoite
and then backwards to the rear of the cell as part of the moving
junction. During this invasion process, MyoB-GFP remained at
the apical tip of themerozoite, did not participate in themoving
junction, andwas still apical in newly invaded ring stages until it
finally disappeared. Although its precise function remains
unknown, it is possible thatMyoB has a role in formation of the
apical polarity of the cell or a structural/mechanical role in
secretory vesicle fusion during the invasion process, consistent
with its static localization. Of course, it would be of great inter-
est to study the effects of deletion of the myob and/or mlc-b
genes on parasite development. We have attempted to knock
outmlc-b in both P. falciparum and P. bergheiwithout success.
This suggests that the MyoBMLC-B complex is likely to be
essential for parasite survival. Experiments are underway to
confirm these datawithmyob. If the complex is confirmed to be
essential, alternative strategies, for example inducible gene
knockouts, will have to be employed to study the consequences
of gene deletions.
Because of the overall predicted structural similarity between
MyoB and MyoA, it was of interest to establish whether or not
MyoB interacted with MTIP or other components of the
glideosome complex.MTIP (MLC1 inT. gondii) had been iden-
tified as one of the light chains for MyoA, and the association
occurred through the degenerate IQ motif at the extreme
C-terminal end ofMyoA (6, 8, 9, 44). Related sequences are also
present at theC terminus ofMyoB.Analysis of immunoprecipi-
tated MyoB-GFP by Western blotting with protein-specific
antibodies provided no evidence for an association of MTIP,
GAP45, orGAP50withMyoB, further confirmed bymass spec-
trometry analysis. In these experiments, we identified a novel
light chain forMyoB, designatedMLC-B.MLC-Bwas shown to
be localized to the apex of merozoites, at a location indistin-
guishable fromMyoB.MLC-B is an unexpectedly large protein,
composed of two parts as follows: the EF-hand containing cal-
modulin-like CTD and the much larger N-terminal domain.
We have demonstrated that the CaM-like CTD of MLC-B is
able to bind a peptide from the extreme C terminus of MyoB.
Like the CaM-like domain of MTIP, this domain in MLC-B
does not possess any of the specific residues likely to be impor-
tant in the coordination of calcium ions by EF-hands (45).
Therefore, although there may be a structural similarity to cal-
modulin in this region, it is unlikely that calcium plays a role in
its function or structure.
MLC-B is the largest myosin light chain to be identified in
any species, and its structure is unique. Light chains are known
to be required for full functioning of myosin motors (38, 46);
however, most are CaM-like molecules with molecular masses
less than 20 kDa (47). MTIP has an N-terminal extension that
has been demonstrated to be important for its interaction with
GAP45, anothermember of the glideosome complex (13); how-
ever the N-terminal extension of MLC-B is far larger, compris-
ing more than 75% of the MLC-B sequence. The N-terminal
region of MLC-B is predicted to primarily contain -helical
structural elements, and in silico analysis of this sequence sug-
gested that it would form a dimeric coiled coil. We have shown
by CD and thermal denaturation experiments that a region of
the predicted coiled coil of PfMLC-B is indeed highly helical
and exhibits concentration-dependent thermal unfolding.
These characteristics are consistent with this region forming a
coiled-coil structure, although we cannot distinguish between
dimeric and trimeric coiled coils using thesemethods. Itmay be
that dimerization of this unusual light chain is the way that the
small tailless MyoB achieves functionality and/or correct local-
ization. To generate movement, intrinsically monomeric myo-
sins require either dimerization or anchoring into a fixed struc-
ture to form an array. For example, the apicomplexan class XIV
myosin MyoA is anchored into the parasite’s inner membrane
complex by virtue of membrane interactions by its associated
molecules, including the light chain MTIP (13, 14, 48), and
dimerization of myosin V (49) and myosin VI (50) is required
for their functions. It may be that the smaller than usual class
XIVmyosins make up for their lack of tail by having larger than
usual light chains that are able to functionally compensate. Fur-
ther work to address the regulation, regions involved in target-
ing to its apical location, and further possible binding partners
of the MyoBMLC-B complex will be crucial to address this
question, which is fundamental to identifying the role ofMyoB.
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